{"name":"J-Pharma Co., Ltd.","slug":"j-pharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Nanvuranlat","genericName":"Nanvuranlat","slug":"nanvuranlat","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Nanvuranlat","genericName":"Nanvuranlat","slug":"nanvuranlat","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFB4RGNSY3RDNE10d2htdDRtcTRRdk0yWHFFTlFVcGNVNFJJOFNMdFVKdHBCRGlOYUh6RXJnSVpFNG50ellMb0pVSXQ4UmlWZ0dwY1M3cXFWbVZuTFh4MjMyVGJR?oc=5","date":"2026-04-03","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQdFNBNWdWNWlJbU9SQ1UzM3l5Mm9mMkszbGVUVXR0UElYQW9fYzRVMzlma0xsbVlyNVgxbm0zNGpMVmRHWXF1TS1qN1FDZWhzREhLekN2a2d2dGJCSkZHSTdBdzIzMEVCQWFrT1F3S0FFcFZMaGxUSDFBYl9JRzNjNmRmZGhqc081Nkw4anByRzdpcWI3blM4RnA2OEszcE5X?oc=5","date":"2026-04-01","type":"pipeline","source":"Moomoo","summary":"Large Shareholding in Jay Pharma (11.34%) JIC Venture Growth I - Moomoo","headline":"Large Shareholding in Jay Pharma (11.34%) JIC Venture Growth I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQVlRkTll3MTFwUmw2M25SeXdYSkxRd2JSZnhSQXhJSzhBb09RblViLVlJR2ZzbHktZnpLaEpRdkdITVBJOExRVkptR19tVmFHZ2p0YVlSeXlLa2o2cGxvYUFnTGpqZkFodlM0SUVFN3hqMUlyUncwWW9CNWt6NElmRHZScUN4cnBrLUNoMk1OajZRNG1uSFRKVmlBbmJSOG9TeF83VmstWWthV0NVMlhoUXpDbC1KeVBYMXgzeGJCd01Nb0xTVHJvQVVOZGxSY2xSMUozQnlBdTcxNHIxVGl4S2FLdzA5b3daM20zcmEyb1czVjhtbW1QOGVKY1QydEdBSzVDOFhYLVlQTkFMdUNyWFI0cmhSYmVOYkljNGZR?oc=5","date":"2026-03-02","type":"regulatory","source":"PR Newswire","summary":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (202","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPNVYteHk1b2ZvNWx3QUdtbGNkYTdpc0xJZnVIUVMzRk1hSXhSMVFBRTNhX0dCU0Z5dlR6ZkpqSlc2eVVoaGlIOGM2Q2lxVVRvdUdvTEw3QkllQkRqWEVTbzJTTXMxOHpIbDh2NkdNWVM0NndHYjZBakdJWTA4TGVVeHdNby14S0JsdVlncHlOQTJtVjlWUTJNaXZUcEx6ZDRfenBFdEtQaldOb2c3UXRyRlppSG9oYWZ5N0c2ZGhWWVNFeXU2eDFsd1NJZUQ0RVlWSHJKMU1hdlVSVGloTXVDRndKdThwZWpO?oc=5","date":"2026-01-05","type":"pipeline","source":"globenewswire.com","summary":"OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer - globenewswire.com","headline":"OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxONlFLbnNHbFZ3TkJrc2YtZ3FsRThMNW1aaHp1d1U0SVVGV09ZLWRXa1BmYVkzSks5SVVaMlAyMnROb0tFeXhLQmFoME15SFcwd1FyMzdZSHRzQXhNZGJqSGE4NDI1Q3loODl5emQzWnlMNmExcTQ1QWtYOGlzekY1d0R0VGV1THJjQTlzc2Z3V0xQMVE1d1Y3bmdrWjN2Um5OQUEzOUhZcXFGOHczVlIwVll5UkVtb2hvY2UtaFlOS3M?oc=5","date":"2025-11-17","type":"pipeline","source":"Fierce Biotech","summary":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances - Fierce Biotech","headline":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNa3RlUjZwVXpwN1pVT0VmYTNkVVlESlRxUU5zcmN3WFJGREtFY0Y3SkRVb2RHWENUVGRQVGRYcjVUTkU4Z0RITGRuQ1hQa1NvSkxJaENwR1FubWRTZ21SOVB1RjVKdTNwMERmMFdHaE9lR0xxWkU1WWxjQjNZYm5BT2pqbFJhU19reHBNbzNSQWtjOFVTZ3lpU3NLbUdUbXRxYllJZ3ByamswQmJ6TFpfSmoxMkJiNm5GdDFrVksyTHQ2cjFnTzJvWk9ZN09yWF9GYW5BOGNMUQ?oc=5","date":"2025-09-22","type":"pipeline","source":"BioSpace","summary":"JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program - BioSpace","headline":"JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxOa3JLNGxYMWJEbGNNTE50el9wcWYwNWZtNjJidkpPd2I5QnBwQUhjaVpMTHJYLVMzSnA4aG96ZjYzNjZxd3BpdFdyVHNyOU1nN1p0REJPUnJjR1NjR0ZwX1N2VzBaaXNxYjVRNUVaYThnODV3dVhEUkZNdURaLU55RTgwRHBUQU5qeXlBSm9WUndJSmViSWl0QmM5ekNEbmwzWlNVMjh0TWw1WF9rSjRWamRiQy1VZWtyc242UkFJSGwwTnJfY0FheWxvUEVHMGd6X0N2N0o4Z0cxQzVzQXNkWFBaenRQVlF0SGl5V0w0MEp0VDQyN2ViU2FqVUEtRWdTWWlHU1ZnakZrRHdWeHZFZUNkNXIybUItM1NTb1hsVU9scy02SDFJ?oc=5","date":"2025-09-08","type":"trial","source":"Business Wire","summary":"JCR Pharmaceuticals Presents Long-Term Clinical Data on Pabinafusp Alfa for the Treatment of Mucopolysaccharidosis Type II (MPS II) at ICIEM 2025 - Business Wire","headline":"JCR Pharmaceuticals Presents Long-Term Clinical Data on Pabinafusp Alfa for the Treatment of Mucopolysaccharidosis Type ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxQT0pEZkxiU3RVdGtubnRuM0RVNzZxZTRxaDFIOFVUTGFLbHNSUUF4M2xCQk1vQTdaSmFlY2VwdU81ckdGcmtxUTZhel9NV0IySHV2TFNha1N4RG13eGRjQl9KYllFbWdYWW1kZmFWY2ZEVXpCWm5qQktRMi0wdGd6NFhKM1NZbU95UjEwa2ozOXd6dkFmM1JHT0NiVjFhdWVmRk5tYks4NnJORGh6RklKWm03bjY0eDN6QTNldU85NkNwMzBoYjd4UzFVX0poOHQ2cUVsLVgyOEJZMWc1MzFGWktIZGxmQ2ptUEFFNlV1ZkZ5NFNsVTVmZDFoN2h0TWNDR0gzS2lJeXZOOExoZ3o3cDhRaC1LZVpMU1FhRm00YlRQaS11akpVWG5RTDVtakVFTE43RHVtTlA?oc=5","date":"2025-07-15","type":"deal","source":"Business Wire","summary":"JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform - Business Wire","headline":"JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer’s Disease, Enable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQTDkteFRWak9LUEZUZy1oZ2hoc1Z0Q1YyUlAtVHBkZHBzbXV0WE9tNExwUEs5SHI5UF9VbEkwNVVRQVVCRHBMSHZEMXExZUpQTDcwYjBuN3Y2OGdHUE93SFZsTVhaMjYtUUJNbEh3RVJiRHZqWHpYSGhfTlluZk9fNHQ5UG1iRlMwWXJodlpsSkxOeEI4ZTI2TjFTYTFrdm55Z0FSMmpMY19VRVJGSFd5NGk3a0NTVGZzUi01ejh0c0paUHBJMC1DZ0pJaUhsdjJ5cDlBRWdjTUxlMllvUXNISHAwUWZZbklJRVI2R09qY25sdVhiUkdrc2EyWVRqQzZIUm1sX2RZTVFaNUpCOXc?oc=5","date":"2025-07-08","type":"deal","source":"BioSpace","summary":"JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines - BioSpace","headline":"JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE8tRk0wR0Q0bE51T0JhYlFrU1lDN0ZIRUhBS2pncTdreUZuZDc2b0RNOVdNcmhBeWtPR1dmWGduZTR5bURGOHhqNkh3ZHpVMFZFc0lkdnBHbWpKR0ZfYXZuUzVTSQ?oc=5","date":"2025-07-07","type":"pipeline","source":"JAL","summary":"Launch of Cell Transport Service for Regenerative Medicine \"J SOLUTIONS PHARMA CELLS\" - JAL","headline":"Launch of Cell Transport Service for Regenerative Medicine \"J SOLUTIONS PHARMA CELLS\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBXSVhQQ1NLZERtRnc4QVgtOTVoYVhKTkR1STd3WF9vVXcwYVlJeXVkcF93MmY2ZmN5VnRzd0ZBSnpOUm1DVHpIdTlJMTB4OVQwRGNBSWRJVGkzRko1WDFv?oc=5","date":"2025-02-14","type":"pipeline","source":"nature.com","summary":"Structural basis of anticancer drug recognition and amino acid transport by LAT1 - nature.com","headline":"Structural basis of anticancer drug recognition and amino acid transport by LAT1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQVXl3dWluaV9keW5sR19XVVlnUjl6VktfdXhIN21rZjE4elNDbldDMERQNmQtRUNJRWtfbHBWMm1sUzVmQkdlWUJKR2ZxR0twTDIwaXpoRGRGU25aT3dzQjRoMkQwVUhCZGw3QVZTR0JuNVlPUFJsYUk3OE9aOXFTa2NxZzl0cGlZNTM3ell5Zi0xRnNuN3lLcEh6MmFYNnZJYlNXMDlya3c0RFY3dWo0MU1OMHphdndZb2tsRk84Nzgtalp0cm40ZnNxcUtqVW1m?oc=5","date":"2024-01-09","type":"pipeline","source":"McKinsey & Company","summary":"Generative AI in the pharmaceutical industry: Moving from hype to reality - McKinsey & Company","headline":"Generative AI in the pharmaceutical industry: Moving from hype to reality - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}